S. Bos (Newcastle upon Tyne, United Kingdom), M. Hellemons (Rotterdam, Netherlands)
Morbimortality of severe early abdominal complications in lung transplanted patients
L. González Ramos (Santander, Spain), J. Osorio Chávez (Santander, Spain), M. Cristeto Porras (Santander, Spain), N. Borja Vargas (Santander, Spain), S. Tello Mena (Santander, Spain), D. Iturbe Fernández (Santander, Spain), V. Mora Cuesta (Santander, Spain), J. Cifrian Martinez (Santander (Cantabria), Spain)
|   |
Sarcopenia and skeletal muscle disfunction in lung transplant candidates
C. Andrade (Santiago, Chile), M. Salinas (Santiago, Chile), S. Valdés (Santiago, Chile), C. Caniulaf (Santiago, Chile), D. Provoste (Santiago, Chile), R. Adasme (Santiago, Chile), V. Linacre (Santiago, Chile)
| |
IMPACT OF NEUTROPENIA AND GRANULOCYTE COLONY-STIMULATING FACTOR TREATMENT IN LUNG TRANSPLANT RECIPIENTS
R. Sanabrias (Madrid, Spain), R. Laporta (Madrid, Spain), M. Aguilar (Madrid, Spain), M. Lázaro (Madrid, Spain), C. García (Madrid, Spain), S. Aguado (Madrid, Spain), A. Royuela (Madrid, Spain), M. Ussetti (Madrid, Spain)
| |
Cystic Lung Diseases and Lung Transplantation
M. Erro Iribarren (Madrid, Spain), R. Gutiérrez-Larraya Sánchez-Andrade (Madrid, Spain), S. Aguado Ibañez (Madrid, Spain), R. Laporta Hernández (Madrid, Spain), M. Aguilar Pérez (Madrid, Spain), C. García Fadul (Madrid, Spain), G. Padín Pico (Madrid, Spain), M. Ussetti Gil (Madrid, Spain)
| |
Renal outcomes according to baseline kidney function after lung or combined heart-lung transplantation for pulmonary hypertension
A. D'Haenens (Leuven, Belgium), L. Vanwalleghem (Leuven, Belgium), R. Quarck (Leuven, Belgium), C. Belge (Leuven, Belgium), G. Claessen (Leuven, Belgium), D. Kuypers (Leuven, Belgium), G. De Vlieger (Leuven, Belgium), T. Verbelen (Leuven, Belgium), L. Ceulemans (Leuven, Belgium), D. Van Raemdonck (Leuven, Belgium), A. Neyrinck (Leuven, Belgium), G. Verleden (Leuven, Belgium), R. Vos (Leuven, Belgium), M. Delcroix (Leuven, Belgium), L. Godinas (Leuven, Belgium)
| |
Right ventricle and lung ischemia-reperfusion injury: Large animal model mimicking hemodynamics during off-pump sequential single-lung transplantation
M. Orlitova (Leuven, Belgium), P. Claus (Leuven, Belgium), A. Frick (Leuven, Belgium), D. Van Beersel (Leuven, Belgium), B. Demeulenaere (Leuven, Belgium), M. Benthami Kbibi (Leuven, Belgium), J. Van Slambrouck (Leuven, Belgium), B. Vanaudenaerde (Leuven, Belgium), G. Verleden (Leuven, Belgium), S. Verleden (Antwerp, Belgium), W. Coudyzer (Leuven, Belgium), R. Vos (Leuven, Belgium), D. Van Raemdonck (Leuven, Belgium), L. Ceulemans (Leuven, Belgium), T. Verbelen (Leuven, Belgium), A. Neyrinck (Leuven, Belgium)
| |
Referral characteristics and outcome of listing for lung transplantation in interstitial lung diseases patients
M. Šterclová (Prague, Czech Republic), L. Valentova-Bartakova (Prague, Czech Republic), L. Fila (Prague, Czech Republic), J. Pozniak (Prague, Czech Republic), M. Svorcova (Prague, Czech Republic), R. Lischke (Prague, Czech Republic)
| |
Lung transplantation for interstitial lung disease: lessons from a UK single centre experience
S. Bos (Newcastle upon Tyne, United Kingdom), S. Leong (Newcastle upon Tyne, United Kingdom), Z. Law (Kuala Lumpur, Malaysia), J. Lordan (Newcastle upon Tyne, United Kingdom), A. Nair (Newcastle upon Tyne, United Kingdom), A. Fisher (Newcastle upon Tyne, United Kingdom), G. Meachery (Newcastle upon Tyne, United Kingdom)
| |
A survey of referral rates for lung transplant assessment in patients with interstitial lung disease meeting pulmonary function criteria
O. Deri (Ramat Gan, Israel), D. Ovadia (Ramat Gan, Israel), M. Peled (Ramat Gan, Israel), S. Chatterji (Ramat Gan, Israel), L. Levy (Ramat Gan, Israel)
| |
Telomere length measurement in the pre lung transplant evaluation of patients with interstitial lung disease
V. Ferraro (Montréal (QC), Canada), B. Nasir (Montréal (QC), Canada), A. Lemay (Montréal (QC), Canada), S. Doucet (Montréal (QC), Canada), G. Huard (Montréal (QC), Canada), C. Poirier (Montréal (QC), Canada), P. Ferraro (Montréal (QC), Canada), J. Morisset (Montréal (QC), Canada)
| |
Downregulation of NLRP3CASP1 and IL1B expression in COPD patients after lung transplantation
I. Markelic (Zagreb, Croatia), L. Rumora (Zagreb, Croatia), I. Hlapcic (Zagreb, Croatia), F. Džubur (Zagreb, Croatia), S. Popovic Grle (Zagreb, Croatia), M. Samaržija (Zagreb, Croatia), A. Vukic Dugac (Zagreb, Croatia)
| |
Airway complications after lung transplantation: risk factors and clinical characteristics
H. Kim (Seoul, Republic of Korea), D. Oh (Seoul, Republic of Korea), K. Jo (Seoul, Republic of Korea), S. Hong (Seoul, Republic of Korea), T. Shim (Seoul, Republic of Korea), G. Lee (Seoul, Republic of Korea), S. Choi (Seoul, Republic of Korea), D. Kim (Seoul, Republic of Korea), S. Park (Seoul, Republic of Korea), H. Kim (Seoul, Republic of Korea)
| |
The impact of donor-recipient sex match in the lung function after lung transplant
A. Cheng (Toronto, Canada), H. Kitazawa (Toronto, Canada), N. Belousova (Toronto, Canada), A. Vasileva (Toronto, Canada), J. Wu (Toronto, Canada), C. Ryan (Toronto, Canada), C. Chow (Toronto, Canada)
| |
Bronchoalveolar lavage lymphocytes as a marker of acute cellular rejection in lung transplant recipients
S. Aguado Ibáñez (Majadahonda, Spain), R. Gutiérrez-Larraya Sánchez-Andrade (Majadahonda, Spain), M. Erro Iribarren (Majadahonda, Spain), G. Padín Pico (Majadahonda, Spain), M. Aguilar Pérez (Majadahonda, Spain), R. Laporta Hernández (Majadahonda, Spain), M. Ussetti Gil (Majadahonda, Spain), B. Jara Chinarro (Majadahonda, Spain)
| |
Morphological changes during CLAD development after lung transplantation
H. Beeckmans (Leuven, Belgium), V. Geudens (Leuven, Belgium), L. Willems (Leuven, Belgium), J. Kaes (Leuven, Belgium), A. Vermaut (Leuven, Belgium), C. De Fays (Leuven, Belgium), A. Neyrinck (Leuven, Belgium), G. Verleden (Leuven, Belgium), L. Dupont (Leuven, Belgium), L. Ceulemans (Leuven, Belgium), D. Van Raemdonck (Leuven, Belgium), R. Vos (Leuven, Belgium), B. Vanaudenaerde (Leuven, Belgium)
| |
Influence of mycophenolate mofetil dosage and plasma levels on the occurrence of chronic lung allograft dysfunction in lung transplants.
C. Steinack (Zurich 8049, Switzerland), P. Saurer (Zurich 8049, Switzerland), F. Gautschi (Zurich 8049, Switzerland), R. Hage (Zurich 8049, Switzerland), G. Ortmanns (Zurich 8049, Switzerland), M. Schuurmans (Zurich 8049, Switzerland), T. Gaisl (Zurich 8049, Switzerland)
| |
Late Breaking Abstract - Donor smoking history does not affect the risk of lung cancer in lung transplantation patients
E. van der Ploeg (Groningen, Netherlands), E. Verschuuren (Groningen, Netherlands), T. Hiltermann (Groningen, Netherlands), J. Van Gemert (Groningen, Netherlands), M. Erasmus (Groningen, Netherlands), C. Van De Wauwer (Groningen, Netherlands), C. Gan (Groningen, Netherlands)
| |
Late Breaking Abstract - Effective home monitoring using portable spirometer of the patient after lung transplantation – feasibility pilot study
M. Basza (Katowice, Poland), W. Bojanowicz (Katowice, Poland), F. Zawadzki (Katowice, Poland), M. Ochman (Katowice, Poland), L. Koltowski (Warsaw, Poland), P. Przybylowski (Katowice, Poland), M. Solinski (Warsaw, Poland)
| |